Mercer’s Musings #5: Pre-IPO Studies/Discounts and Marketability Discounts
![](https://i0.wp.com/chrismercer.net/content/uploads/2024/03/shutterstock_1414636532.jpg?fit=500%2C334&ssl=1)
My musings on the use of restricted stock discounts to estimate marketability discounts (or DLOMs) have led me to the conclusion: Restricted stock studies/discounts cannot be used to estimate DLOMs in any credible, standards-compliant manner. This fifth post in the musings series takes a look at the usefulness of pre-IPO discounts in estimating marketability discounts.